Laura Yecies is a leader in medical technology, dedicated to transforming healthcare through innovation. As CEO of Osteoboost Health, she is tackling the global low bone density epidemic with the Osteoboost device, the first FDA-cleared treatment for osteopenia in postmenopausal women. A seasoned executive, she has led NeuroSync, Catch (acquired by Apple), and SugarSync (acquired by J2Global). Earlier, she led Netscape’s Browser division, Yahoo Mail, and global marketing at Check Point. She holds degrees from Harvard, Georgetown, and Dartmouth.